Specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products.
Year of Incorporation:
Chief Executive Officer:
Dr. Naruhito Higo
Media, General Business
& Other Inquiries:
Partnering and Other Business Development Opportunities
Sr. Manager –
Corporate Social Responsibility
Noven is a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc. – bringing the benefits of patch therapy to patients around the world.
Noven's commercialized products are marketed and sold through Noven Therapeutics, LLC.
Grove Pharmaceuticals is the generic division of Noven Therapeutics, LLC.